48,868
edits
Difference between revisions of "Quality"
Jump to navigation
Jump to search
m
→Classification of IHC tests
| Line 156: | Line 156: | ||
**Used by clinicans for treatment decisions. | **Used by clinicans for treatment decisions. | ||
**Considered independent of the other information in the pathology report; thus, cannot be derived from other information in the report. | **Considered independent of the other information in the pathology report; thus, cannot be derived from other information in the report. | ||
**Examples: ER, PR, HER2. | **Examples: ER, PR, HER2, Ki-67, CD117, CD20. | ||
The implication of irregularies in the different classes are different. Problems in ''Class II'' tests are potentially more severe, as there is no internal control. | The implication of irregularies in the different classes are different. Problems in ''Class II'' tests are potentially more severe, as there is no internal control. | ||